Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants
Authors (first, second and last of 9)
Collection
Liquid Biopsy in Breast Cancer
Liquid biopsy, the analysis of circulating markers in the blood of cancer patients, is a fast-moving research space. There is tremendous excitement for the clinical adoption of liquid biopsy given the potential for it to revolutionise cancer screening, including breast cancer screening.
In this collection, we welcome studies investigating the diverse range of circulating markers - such as circulating DNA (ctDNA), circulating tumour cells and exosomes - for breast cancer diagnosis and treatment.
Articles (10 in this collection)
-
-
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
Authors (first, second and last of 12)
-
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study
Authors (first, second and last of 9)
-
Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer
Authors (first, second and last of 8)
-
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer
Authors (first, second and last of 13)
-
Heterogeneous circulating tumor cells correlate with responses to neoadjuvant chemotherapy and prognosis in patients with locally advanced breast cancer
Authors (first, second and last of 9)
-
Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy
Authors (first, second and last of 10)
-
Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score
Authors (first, second and last of 8)
-
Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment
Authors (first, second and last of 9)
-
Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patients
Authors (first, second and last of 9)
